title: Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98.
authors.forename: B
authors.initials: B
authors.lastname: Stark
authors.forename: R
authors.initials: R
authors.lastname: Nirel
authors.forename: G
authors.initials: G
authors.lastname: Avrahami
authors.forename: A
authors.initials: A
authors.lastname: Abramov
authors.forename: D
authors.initials: D
authors.lastname: Attias
authors.forename: A
authors.initials: A
authors.lastname: Ballin
authors.forename: B
authors.initials: B
authors.lastname: Bielorai
authors.forename: Y
authors.initials: Y
authors.lastname: Burstein
authors.forename: H
authors.initials: H
authors.lastname: Gavriel
authors.forename: R
authors.initials: R
authors.lastname: Elhasid
authors.forename: J
authors.initials: J
authors.lastname: Kapelushnik
authors.forename: D
authors.initials: D
authors.lastname: Sthoeger
authors.forename: A
authors.initials: A
authors.lastname: Toren
authors.forename: M
authors.initials: M
authors.lastname: Wientraub
authors.forename: I
authors.initials: I
authors.lastname: Yaniv
authors.forename: S
authors.initials: S
authors.lastname: Izraeli
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016130:Immunophenotyping; D007223:Infant; D007557:Israel; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D018365:Neoplasm, Residual; D016609:Neoplasms, Second Primary / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D012074:Remission Induction; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome